Related Experiment Video
Updated: Oct 25, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
Robert J Ragotte1,2, David Pulido1,2, Francesca R Donnellan1,2
1Jenner Institute, University of Oxfordgrid.4991.5, Oxford, United Kingdom.
Abstract:
Basigin, or CD147, has been reported as a coreceptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to invade host cells. Basigin also has a well-established role in Plasmodium falciparum malaria infection of human erythrocytes, where it is bound by one of the parasite's invasion ligands, reticulocyte binding protein homolog 5 (RH5). Here, we sought to validate the claim that the receptor binding domain (RBD) of SARS-CoV-2 spike glycoprotein can form a complex with basigin, using RH5-basigin as a positive control. Using recombinantly expressed proteins, size exclusion chromatography and surface plasmon resonance, we show that neither RBD nor full-length spike glycoprotein bind to recombinant human basigin (expressed in either Escherichia coli or mammalian cells). Further, polyclonal anti-basigin IgG did not block SARS-CoV-2 infection of Vero E6 cells. Given the immense interest in SARS-CoV-2 therapeutic targets to improve treatment options for those who become seriously ill with coronavirus disease 2019 (COVID-19), we would caution the inclusion of basigin in this list on the basis of its reported direct interaction with SARS-CoV-2 spike glycoprotein. IMPORTANCE Reducing the mortality and morbidity associated with COVID-19 remains a global health priority. Vaccines have proven highly effective at preventing infection and hospitalization, but efforts must continue to improve treatment options for those who still become seriously ill. Critical to these efforts is the identification of host factors that are essential to viral entry and replication. Basigin, or CD147, was previously identified as a possible therapeutic target based on the observation that it may act as a coreceptor for SARS-CoV-2, binding to the receptor binding domain of the spike protein. Here, we show that there is no direct interaction between the RBD and basigin, casting doubt on its role as a coreceptor and plausibility as a therapeutic target.
Insights
This study found no direct interaction between SARS-CoV-2 spike protein and basigin (CD147), questioning its role as a host cell entry coreceptor for COVID-19 treatment. Further research is needed to identify effective therapeutic targets.
Area of Science:
- Virology
- Immunology
- Parasitology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes host cell receptors for entry.
- Basigin (CD147) was proposed as a SARS-CoV-2 coreceptor, binding the spike protein's receptor binding domain (RBD).
- Basigin is also implicated in Plasmodium falciparum malaria invasion.
Purpose of the Study:
- To validate the interaction between SARS-CoV-2 spike glycoprotein (RBD) and basigin.
- To assess basigin's potential as a therapeutic target for COVID-19.
Main Methods:
- Recombinant protein expression (E. coli and mammalian cells).
- Size exclusion chromatography and surface plasmon resonance assays.
- Inhibition assays using anti-basigin IgG in Vero E6 cells.
Main Results:
- No binding was detected between SARS-CoV-2 RBD or full-length spike glycoprotein and recombinant human basigin.
- Polyclonal anti-basigin IgG did not inhibit SARS-CoV-2 infection of host cells.
- The positive control (RH5-basigin interaction) was confirmed.
Conclusions:
- The direct interaction between SARS-CoV-2 spike protein and basigin is not supported by this study.
- Basigin's role as a SARS-CoV-2 coreceptor is questionable.
- Caution is advised regarding basigin as a direct therapeutic target for COVID-19.
More Related Videos
06:39High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...